We are live on ! Find out more
SL

SIB LLC Portfolio holdings

AUM $190M
1-Year Est. Return 9.27%
This Fund
S&P 500
This Quarter Est. Return
+9.92%
1 Year Est. Return
+9.27%
3 Year Est. Return
+29.19%
5 Year Est. Return
+154.91%
10 Year Est. Return
+361.81%
AUM
$136M
AUM Growth
-$5.13M
Cap. Flow
-$17M
Cap. Flow %
-12.51%
Top 10 Hldgs %
82.12%
Holding
26
New
2
Increased
–
Reduced
15
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.6M
2
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$118K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.52M
2
ODFL icon
Old Dominion Freight Line
ODFL
+$3.23M
3
LULU icon
lululemon athletica
LULU
+$1.98M
4
JBHT icon
JB Hunt Transport Services
JBHT
+$1.97M
5
PWR icon
Quanta Services
PWR
+$1.54M

Sector Composition

Rank Sector Weight
1 Industrials 53.47%
2 Consumer Discretionary 44.1%
3 Healthcare 2.15%
4 Energy 0.13%
5 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
26
DELISTED
Celgene Corp
CELG
– –
-45,477
Closed -$4.52M
1
2

Similar funds

QS
Quantitative Strategies Calabasas, California $187M AUM 10.84% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
LHR
Lunate Holding RSC Al Maryah Island, Abu Dhabi, United Arab Emirates $211M AUM
CM
Cigogne Management Luxembourg $169M AUM
KWM
Kolinsky Wealth Management Ramsey, New Jersey $164M AUM 29.71% 1-Year Est. Return
HFS
HBC Financial Services Seattle, Washington $163M AUM 14.55% 1-Year Est. Return
CCA
Criterion Capital Advisors Nashville, Tennessee $159M AUM 13.22% 1-Year Est. Return

SIB LLC's Q4 2019 Portfolio in Review

As of Q4 2019, SIB LLC held 26 positions worth $136M, down 3.6% from $141M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

SIB LLC withdrew a net $17M in Q4 2019, closing 2 positions and reducing 15 holdings. Its most notable exit was Celgene Corp, an estimated $4.52M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 53% of assets, up from 53% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, SIB LLC opened a new position in Bristol-Myers Squibb worth $2.92M.

  • SIB LLC's largest Q4 2019 buy was Bristol-Myers Squibb: 45,477 shares worth $2.92M.
  • SIB LLC's biggest Q4 2019 reduction was Old Dominion Freight Line, cutting an estimated $3.23M.
  • SIB LLC fully exited Celgene Corp in Q4 2019, selling an estimated $4.52M.
  • SIB LLC's ten largest holdings make up 82% of its $136M portfolio in Q4 2019.
  • SIB LLC opened 2 new positions and closed 2 in Q4 2019.
  • SIB LLC's portfolio value fell 3.6% quarter-over-quarter to $136M.

Based on SIB LLC's 13F filing for Q4 2019, filed 21 Jan 2020.